English language
Toggle Transcript
reboxetine::noun | Spocien Dictionary
| Type | Words |
|---|---|
| Synonyms | edronax |
| Type of | antidepressant, antidepressant drug |
Examples of reboxetine
reboxetine
Published trials, however, show a favourable risk-benefit profile for reboxetine.
From the sciencedaily.com
The researchers found that almost three-quarters of data on reboxetine was unpublished.
From the theepochtimes.com
They show that reboxetine is, overall, an ineffective and potentially harmful antidepressant.
From the sciencedaily.com
When the totality of the evidence was assessed, it turns out that reboxetine was no better than placebo.
From the theepochtimes.com
Reboxetine allowed participants to detect sour tastes at 22% lower concentrations than before treatment.
From the newscientist.com
It is interesting to note that in the United States, reboxetine was originally licensed, but then its license was revoked.
From the theepochtimes.com
There is an antidepressant called reboxetine, which never made it to the U.S. but is widely used in Europe and Canada.
From the us.cnn.com
Reboxetine works entirely through the norepinephrine system and has no direct effects on serotonin whatsoever.
From the us.cnn.com
Pfizer has been accused by scientists of failing to disclose studies which show the inadequacies of reboxetine.
From the guardian.co.uk
- An antidepressant drug that blocks the reuptake of norepinephrine
- Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD, developed by Pharmacia (now Pfizer). Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra.
